Foundry Long-Term Reversal Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1EL | ESTEE LAUDER COMPANIES INC | Consumer Defensive | $29.71B | 6.30% |
2ILMN | ILLUMINA INC | Healthcare | $28.24B | 5.99% |
3ZM | ZOOM COMMUNICATIONS INC | Technology | $26.72B | 5.66% |
4MRNA | MODERNA INC | Healthcare | $24.53B | 5.20% |
5ROKU | ROKU INC | Communication Services | $21.32B | 4.52% |
6U | UNITY SOFTWARE INC | Technology | $12.66B | 2.68% |
7W | WAYFAIR INC | Consumer Cyclical | $11.79B | 2.50% |
8ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | $10.47B | 2.22% |
9DOCU | DOCUSIGN INC | Technology | $10.07B | 2.13% |
10MTCH | MATCH GROUP INC | Communication Services | $9.13B | 1.94% |
11WULF | TERAWULF INC | Financial Services | $9.00B | 1.91% |
12PRAX | PRAXIS PRECISION MEDICINES INC | Healthcare | $8.77B | 1.86% |
13SYRE | SPYRE THERAPEUTICS INC | Healthcare | $8.70B | 1.84% |
14IBRX | IMMUNITYBIO INC | Healthcare | $8.04B | 1.70% |
15VFC | V F CORP | Consumer Cyclical | $6.65B | 1.41% |
16PATH | UIPATH INC | Technology | $6.30B | 1.33% |
17ERAS | ERASCA INC | Healthcare | $5.96B | 1.26% |
18DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | $5.77B | 1.22% |
19TXG | 10X GENOMICS INC | Healthcare | $5.55B | 1.18% |
20ENPH | ENPHASE ENERGY INC | Technology | $5.48B | 1.16% |
21DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 1.02% |
22LFST | LIFESTANCE HEALTH GROUP INC | Healthcare | $4.49B | 0.95% |
23BILL | BILL HOLDINGS INC | Technology | $4.45B | 0.94% |
24RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.81% |
25CALY | CALLAWAY GOLF CO | Consumer Cyclical | $3.48B | 0.74% |
26RNG | RINGCENTRAL INC | Technology | $3.46B | 0.73% |
27RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.73% |
28SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.69% |
29FSLY | FASTLY INC | Technology | $3.24B | 0.69% |
30ONDS | ONDAS INC | Technology | $3.23B | 0.69% |
31AAP | ADVANCE AUTO PARTS INC | Consumer Cyclical | $3.19B | 0.68% |
32AXTI | AXT INC | Technology | $3.00B | 0.64% |
33LCID | LUCID GROUP INC | Consumer Cyclical | $2.87B | 0.61% |
34BEAM | BEAM THERAPEUTICS INC | Healthcare | $2.83B | 0.60% |
35RUN | SUNRUN INC | Technology | $2.83B | 0.60% |
36XRAY | DENTSPLY SIRONA INC | Healthcare | $2.81B | 0.60% |
37PENN | PENN ENTERTAINMENT INC | Consumer Cyclical | $2.75B | 0.58% |
38KOD | KODIAK SCIENCES INC | Healthcare | $2.67B | 0.57% |
39ATAI | ATAIBECKLEY INC | Healthcare | $2.66B | 0.56% |
40PTON | PELOTON INTERACTIVE INC | Consumer Cyclical | $2.55B | 0.54% |
41SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $2.45B | 0.52% |
42NKTR | NEKTAR THERAPEUTICS | Healthcare | $2.31B | 0.49% |
43BAND | BANDWIDTH INC | Technology | $2.30B | 0.49% |
44PVLA | PALVELLA THERAPEUTICS INC | Healthcare | $2.26B | 0.48% |
45NEOG | NEOGEN CORP | Healthcare | $2.24B | 0.47% |
46IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | $2.23B | 0.47% |
47NWL | NEWELL BRANDS INC | Consumer Defensive | $2.22B | 0.47% |
48AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.46% |
49OMCL | OMNICELL INC | Healthcare | $2.09B | 0.44% |
50GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | $2.07B | 0.44% |
51CDNA | CAREDX INC | Healthcare | $2.05B | 0.44% |
52NUVB | NUVATION BIO INC | Healthcare | $2.03B | 0.43% |
53ZD | ZIFF DAVIS INC | Communication Services | $1.99B | 0.42% |
54ABCL | ABCELLERA BIOLOGICS INC | Healthcare | $1.97B | 0.42% |
55KSS | KOHLS CORP | Consumer Cyclical | $1.96B | 0.42% |
56FIVN | FIVE9 INC | Technology | $1.96B | 0.42% |
57DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.41% |
58APPN | APPIAN CORP | Technology | $1.92B | 0.41% |
59NEO | NEOGENOMICS INC | Healthcare | $1.90B | 0.40% |
60WGS | GENEDX HOLDINGS CORP | Healthcare | $1.88B | 0.40% |
61MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | Healthcare | $1.87B | 0.40% |
62MQ | MARQETA INC | Technology | $1.85B | 0.39% |
63NVCR | NOVOCURE LTD | Healthcare | $1.84B | 0.39% |
64SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.82B | 0.39% |
65ASAN | ASANA INC | Technology | $1.77B | 0.38% |
66HYMC | HYCROFT MINING HOLDING CORP | Basic Materials | $1.74B | 0.37% |
67BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.37% |
68SHLS | SHOALS TECHNOLOGIES GROUP INC | Technology | $1.73B | 0.37% |
69FIGS | FIGS INC | Consumer Cyclical | $1.72B | 0.37% |
70TSHA | TAYSHA GENE THERAPIES INC | Healthcare | $1.71B | 0.36% |
71TDOC | TELADOC HEALTH INC | Healthcare | $1.70B | 0.36% |
72CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.35% |
73TE | T1 ENERGY INC | Industrials | $1.63B | 0.35% |
74VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.34% |
75NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.34% |
76INNV | INNOVAGE HOLDING CORP | Healthcare | $1.56B | 0.33% |
77LEG | LEGGETT & PLATT INC | Consumer Cyclical | $1.50B | 0.32% |
78IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Healthcare | $1.50B | 0.32% |
79ULCC | FRONTIER GROUP HOLDINGS INC | Industrials | $1.43B | 0.30% |
80AMN | AMN HEALTHCARE SERVICES INC | Healthcare | $1.36B | 0.29% |
81NVAX | NOVAVAX INC | Healthcare | $1.35B | 0.29% |
82BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.29% |
83GPRE | GREEN PLAINS INC | Basic Materials | $1.35B | 0.29% |
84LZ | LEGALZOOMCOM INC | Industrials | $1.33B | 0.28% |
85STAA | STAAR SURGICAL CO | Healthcare | $1.32B | 0.28% |
86XNCR | XENCOR INC | Healthcare | $1.30B | 0.27% |
87ABSI | ABSCI CORP | Healthcare | $1.29B | 0.27% |
88FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.27% |
89HLF | HERBALIFE LTD | Consumer Defensive | $1.24B | 0.26% |
90SAFE | SAFEHOLD INC | Real Estate | $1.22B | 0.26% |
91AMRC | AMERESCO INC | Industrials | $1.22B | 0.26% |
92QDEL | QUIDELORTHO CORP | Healthcare | $1.19B | 0.25% |
93TNDM | TANDEM DIABETES CARE INC | Healthcare | $1.17B | 0.25% |
94XIFR | XPLR INFRASTRUCTURE LP | Utilities | $1.13B | 0.24% |
95UPWK | UPWORK INC | Industrials | $1.12B | 0.24% |
96FUBO | FUBOTV INC | Communication Services | $1.05B | 0.22% |
97JBIO | JADE BIOSCIENCES INC | Healthcare | $1.03B | 0.22% |
98AVTX | AVALO THERAPEUTICS INC | Healthcare | $1.02B | 0.22% |
99APPS | DIGITAL TURBINE INC | Technology | $1.01B | 0.21% |
100OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | $1.00B | 0.21% |
101FBRX | FORTE BIOSCIENCES INC | Healthcare | $1.00B | 0.21% |
102VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.21% |
103ANNX | ANNEXON INC | Healthcare | $950M | 0.20% |
104COUR | COURSERA INC | Consumer Defensive | $941M | 0.20% |
105SLDB | SOLID BIOSCIENCES INC | Healthcare | $859M | 0.18% |
106HPP | HUDSON PACIFIC PROPERTIES INC | Real Estate | $853M | 0.18% |
107CYRX | CRYOPORT INC | Industrials | $832M | 0.18% |
108BKSY | BLACKSKY TECHNOLOGY INC | Technology | $823M | 0.17% |
109RPD | RAPID7 INC | Technology | $815M | 0.17% |
110RJET | REPUBLIC AIRWAYS HOLDINGS INC | Industrials | $806M | 0.17% |
111FOXF | FOX FACTORY HOLDING CORP | Consumer Cyclical | $798M | 0.17% |
112ACRS | ACLARIS THERAPEUTICS INC | Healthcare | $793M | 0.17% |
113DSGN | DESIGN THERAPEUTICS INC | Healthcare | $785M | 0.17% |
114HIPO | HIPPO HOLDINGS INC | Financial Services | $764M | 0.16% |
115GDOT | GREEN DOT CORP | Financial Services | $760M | 0.16% |
116OMER | OMEROS CORP | Healthcare | $701M | 0.15% |
117SWIM | LATHAM GROUP INC | Basic Materials | $692M | 0.15% |
118BALY | BALLY'S CORP | Consumer Cyclical | $688M | 0.15% |
119HELE | HELEN OF TROY LTD | Consumer Defensive | $655M | 0.14% |
120TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Healthcare | $648M | 0.14% |
121TREE | LENDINGTREE INC | Financial Services | $645M | 0.14% |
122TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.13% |
123ILPT | INDUSTRIAL LOGISTICS PROPERTIES TRUST | Real Estate | $591M | 0.13% |
124NGNE | NEUROGENE INC | Healthcare | $590M | 0.12% |
125MYGN | MYRIAD GENETICS INC | Healthcare | $584M | 0.12% |
126PACK | RANPAK HOLDINGS CORP | Consumer Cyclical | $583M | 0.12% |
127STTK | SHATTUCK LABS INC | Healthcare | $577M | 0.12% |
128FDMT | 4D MOLECULAR THERAPEUTICS INC | Healthcare | $575M | 0.12% |
129FLGT | FULGENT GENETICS INC | Healthcare | $573M | 0.12% |
130RLMD | RELMADA THERAPEUTICS INC | Healthcare | $550M | 0.12% |
131XMAX | XMAX INC | Consumer Cyclical | $541M | 0.11% |
132TOI | ONCOLOGY INSTITUTE INC | Healthcare | $535M | 0.11% |
133MEI | METHODE ELECTRONICS INC | Technology | $532M | 0.11% |
134VSTM | VERASTEM INC | Healthcare | $530M | 0.11% |
135CTEV | CLARITEV CORP | Healthcare | $518M | 0.11% |
136SPT | SPROUT SOCIAL INC | Technology | $518M | 0.11% |
137ZURA | ZURA BIO LTD | Healthcare | $518M | 0.11% |
138ARVN | ARVINAS INC | Healthcare | $517M | 0.11% |
139DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | $517M | 0.11% |
140RGNX | REGENXBIO INC | Healthcare | $511M | 0.11% |
141ADV | ADVANTAGE SOLUTIONS INC | Communication Services | $508M | 0.11% |
142SPIR | SPIRE GLOBAL INC | Industrials | $488M | 0.10% |
143MAGN | MAGNERA CORP | Basic Materials | $487M | 0.10% |
144AMCX | AMC GLOBAL MEDIA INC | Communication Services | $461M | 0.10% |
145PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.10% |
146ALTO | ALTO INGREDIENTS INC | Basic Materials | $453M | 0.10% |
147MATV | MATIV HOLDINGS INC | Basic Materials | $442M | 0.09% |
148BETR | BETTER HOME & FINANCE HOLDING CO | Financial Services | $442M | 0.09% |
149BNTC | BENITEC BIOPHARMA INC | Healthcare | $439M | 0.09% |
150BNED | BARNES & NOBLE EDUCATION INC | Consumer Cyclical | $437M | 0.09% |
151ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.09% |
152TENX | TENAX THERAPEUTICS INC | Healthcare | $420M | 0.09% |
153QMCO | QUANTUM CORP | Technology | $419M | 0.09% |
154CBIO | CRESCENT BIOPHARMA INC | Healthcare | $407M | 0.09% |
155ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | $400M | 0.08% |
156ABEO | ABEONA THERAPEUTICS INC | Healthcare | $399M | 0.08% |
157EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $394M | 0.08% |
158STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.08% |
159CRNC | CERENCE INC | Technology | $390M | 0.08% |
160ABTC | AMERICAN BITCOIN CORP | Financial Services | $386M | 0.08% |
161BBBY | BED BATH & BEYOND INC | Consumer Cyclical | $372M | 0.08% |
162ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.08% |
163FNKO | FUNKO INC | Consumer Cyclical | $326M | 0.07% |
164BKKT | BAKKT INC | Technology | $323M | 0.07% |
165VELO | VELO3D INC | Technology | $316M | 0.07% |
166MKTW | MARKETWISE INC | Technology | $314M | 0.07% |
167LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $311M | 0.07% |
168OFLX | OMEGA FLEX INC | Industrials | $302M | 0.06% |
169TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.06% |
170DBI | DESIGNER BRANDS INC | Consumer Cyclical | $290M | 0.06% |
171JACK | JACK IN THE BOX INC | Consumer Cyclical | $286M | 0.06% |
172MASS | 908 DEVICES INC | Healthcare | $278M | 0.06% |
173SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.06% |
174SSTK | SHUTTERSTOCK INC | Communication Services | $272M | 0.06% |
175ZSQR | Z SQUARED INC | Healthcare | $260M | 0.06% |
176TBI | TRUEBLUE INC | Industrials | $258M | 0.05% |
177QTTB | Q32 BIO INC | Healthcare | $255M | 0.05% |
178SRZN | SURROZEN INC | Healthcare | $255M | 0.05% |
179NUS | NU SKIN ENTERPRISES INC | Consumer Defensive | $254M | 0.05% |
180RILY | BRC GROUP HOLDINGS INC | Financial Services | $254M | 0.05% |
181ANGI | ANGI INC | Communication Services | $248M | 0.05% |
182RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $243M | 0.05% |
183GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $240M | 0.05% |
184RMAX | RE/MAX HOLDINGS INC | Real Estate | $236M | 0.05% |
185RDNW | RIDENOW GROUP INC | Consumer Cyclical | $229M | 0.05% |
186UP | WHEELS UP EXPERIENCE INC | Industrials | $229M | 0.05% |
187CABO | CABLE ONE INC | Communication Services | $223M | 0.05% |
188KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.05% |
189SENS | SENSEONICS HOLDINGS INC | Healthcare | $214M | 0.05% |
190AGEN | AGENUS INC | Healthcare | $209M | 0.04% |
191IMUX | IMMUNIC INC | Healthcare | $207M | 0.04% |
192BDSX | BIODESIX INC | Healthcare | $204M | 0.04% |
193FOCL | FOCAL INC | Healthcare | $204M | 0.04% |
194DTIL | PRECISION BIOSCIENCES INC | Healthcare | $203M | 0.04% |
195ANIK | ANIKA THERAPEUTICS INC | Healthcare | $203M | 0.04% |
196FORR | FORRESTER RESEARCH INC | Industrials | $200M | 0.04% |
197AMWL | AMERICAN WELL CORP | Healthcare | $199M | 0.04% |
198TNXP | TONIX PHARMACEUTICALS HOLDING CORP | Healthcare | $198M | 0.04% |
199SRI | STONERIDGE INC | Consumer Cyclical | $197M | 0.04% |
200COOK | TRAEGER INC | Consumer Cyclical | $193M | 0.04% |
201EAF | GRAFTECH INTERNATIONAL LTD | Industrials | $181M | 0.04% |
202INGN | INOGEN INC | Healthcare | $178M | 0.04% |
203KRRO | KORRO BIO INC | Healthcare | $177M | 0.04% |
204LEE | LEE ENTERPRISES INC | Consumer Cyclical | $175M | 0.04% |
205MRDN | MERIDIAN HOLDINGS INC | Communication Services | $171M | 0.04% |
206CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | Healthcare | $167M | 0.04% |
207KORE | KORE GROUP HOLDINGS INC | Communication Services | $163M | 0.03% |
208OWLT | OWLET INC | Healthcare | $162M | 0.03% |
209CHPT | CHARGEPOINT HOLDINGS INC | Consumer Cyclical | $146M | 0.03% |
210UNCY | UNICYCIVE THERAPEUTICS INC | Healthcare | $144M | 0.03% |
211RRGB | RED ROBIN GOURMET BURGERS INC | Consumer Cyclical | $130M | 0.03% |
212FIRY | FIRY INC | Technology | $130M | 0.03% |
213VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.03% |
214BOOM | DMC GLOBAL INC | Energy | $128M | 0.03% |
215JYNT | JOINT CORP | Healthcare | $127M | 0.03% |
216CUE | CUE BIOPHARMA INC | Healthcare | $126M | 0.03% |
217OPRX | OPTIMIZERX CORP | Healthcare | $126M | 0.03% |
218VATE | INNOVATE CORP | Industrials | $123M | 0.03% |
219INSG | INSEEGO CORP | Technology | $122M | 0.03% |
220SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.03% |
221UFI | UNIFI INC | Consumer Cyclical | $118M | 0.02% |
222MED | MEDIFAST INC | Consumer Cyclical | $114M | 0.02% |
223TCX | TUCOWS INC | Technology | $114M | 0.02% |
224SCOR | COMSCORE INC | Communication Services | $113M | 0.02% |
225VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | $96M | 0.02% |
226CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.02% |
227LIXT | LIXTE BIOTECHNOLOGY HOLDINGS INC | Healthcare | $91M | 0.02% |
228RLYB | RALLYBIO CORP | Healthcare | $87M | 0.02% |
229INTG | INTERGROUP CORP | Consumer Cyclical | $84M | 0.02% |
230WATT | ENERGOUS CORP | Technology | $83M | 0.02% |
231VNCE | VINCE HOLDING CORP | Consumer Cyclical | $83M | 0.02% |
232FRMM | FORUM MARKETS INC | Healthcare | $83M | 0.02% |
233AUC | ATIF HOLDINGS LTD | Financial Services | $82M | 0.02% |
234BARK | BARK INC | Consumer Cyclical | $82M | 0.02% |
235PIII | P3 HEALTH PARTNERS INC | Healthcare | $78M | 0.02% |
236SEAT | VIVID SEATS INC | Communication Services | $78M | 0.02% |
237ACET | ADICET BIO INC | Healthcare | $76M | 0.02% |
238AIRG | AIRGAIN INC | Technology | $76M | 0.02% |
239ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $76M | 0.02% |
240BNAI | BRAND ENGAGEMENT NETWORK INC | Technology | $76M | 0.02% |
241CLNN | CLENE INC | Healthcare | $76M | 0.02% |
242BODI | BEACHBODY COMPANY INC | Communication Services | $75M | 0.02% |
243RGS | REGIS CORP | Consumer Cyclical | $74M | 0.02% |
244LVO | LIVEONE INC | Communication Services | $72M | 0.02% |
245NMAD | NOMAD POWER SOLUTIONS INC | Healthcare | $72M | 0.02% |
246SCLX | SCILEX HOLDING CO | Healthcare | $72M | 0.02% |
247ASPS | ALTISOURCE PORTFOLIO SOLUTIONS SA | Real Estate | $72M | 0.02% |
248AGPU | AXE COMPUTE INC | Healthcare | $72M | 0.02% |
249LONA | LEONABIO INC | Healthcare | $68M | 0.01% |
250NDLS | NOODLES & CO | Consumer Cyclical | $66M | 0.01% |
251IMA | IMAGENEBIO INC | Healthcare | $61M | 0.01% |
252EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.01% |
253SKIL | SKILLSOFT CORP | Consumer Defensive | $58M | 0.01% |
254STEM | STEM INC | Technology | $56M | 0.01% |
255TACT | TRANSACT TECHNOLOGIES INC | Technology | $54M | 0.01% |
256MCRB | SERES THERAPEUTICS INC | Healthcare | $52M | 0.01% |
257TIL | INSTIL BIO INC | Healthcare | $50M | 0.01% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $471.78B. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 70% toward Large, 64% toward Growth. +23% unclassified (60 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 2002 → July 2026; the right-hand end is the same value as the box’s dot. 257 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual31.3%Margin-6.3%
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 257 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 283 monthly observations · about 2.8 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (22 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 18.0% | 0.6% |
| 3 yearsp.a. | 1.5% | -22.0% |
| 5 yearsp.a. | 7.5% | -10.7% |
| 10 yearsp.a. | 4.9% | -14.9% |
| Since inceptionp.a. | 6.9% | -7.7% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 1.7% | -6.4% |
| 2025 | 4.8% | -19.4% |
| 2024 | -4.9% | -35.7% |
| 2023 | 16.7% | -28.9% |
| 2022 | 17.2% | 80.5% |
| 2021 | 29.1% | -2.5% |
| 2020 | -11.5% | -40.3% |
| 2019 | 8.5% | -20.5% |
| 2018 | -21.3% | -21.4% |
| 2017 | 7.4% | -19.3% |
| 2016 | 26.3% | 29.9% |
| 2015 | -22.3% | -24.6% |
| 2014 | 10.0% | 3.6% |
| 2013 | 43.5% | 11.8% |
| 2012 | 45.7% | 27.7% |
| 2011 | -29.3% | -32.8% |
| 2010 | 19.6% | -0.4% |
| 2009 | 28.3% | -19.2% |
| 2008 | -24.1% | 60.3% |
| 2007 | 0.0% | -27.1% |
| 2006 | 7.7% | 8.9% |
| 2005 | 5.4% | -3.7% |
| 2004 | 6.7% | -13.8% |
| 2003 | 48.4% | -1.1% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry Long-Term Reversal Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Long-Term Reversal signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.